Industry Research Reports
Home > Reports > Medical Devices & Consumables > Hydrogel-based Drug Delivery Device- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Hydrogel-based Drug Delivery Device- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Industry: Medical Devices & Consumables
Published Date: 2026-01-19
Pages: 153 Pages
Report ld: 5717723
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
The global market for Hydrogel-based Drug Delivery Device was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Hydrogel-based Drug Delivery Device cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
A hydrogel-based drug delivery device refers to a biomedical technology that uses hydrogels as matrices or carriers for controlled and targeted release of therapeutic agents. Hydrogels are three-dimensional networks of cross-linked hydrophilic polymers capable of absorbing and retaining large amounts of water. These devices are designed to encapsulate drugs or biomolecules, providing a stable environment for sustained or localized release in response to physiological stimuli such as pH, temperature, or enzymatic activity. Hydrogel-based drug delivery systems offer advantages like enhanced bioavailability, reduced systemic side effects, and prolonged therapeutic efficacy. They are utilized in various medical applications including wound healing, tissue engineering, cancer therapy, and treatment of chronic diseases, demonstrating versatility and potential for personalized medicine approaches.
The North American market for Hydrogel-based Drug Delivery Device was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.
The Asia-Pacific market for Hydrogel-based Drug Delivery Device was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.
The European market for Hydrogel-based Drug Delivery Device was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.
The global key companies in the Hydrogel-based Drug Delivery Device market include AstraZeneca Plc., Columbia Laboratories Inc., Mylan, Teva Pharmaceuticals USA Inc., Blairex Laboratories Inc., ARx LLC., Endo International plc, BioDelivery Sciences International Inc., Indivior PLC, GSK Plc, etc. In 2025, the five largest players accounted for approximately % of revenue.
This report provides a comprehensive view of the global market for Hydrogel-based Drug Delivery Device, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Hydrogel-based Drug Delivery Device market size, estimations, and forecasts are presented in terms of sales volume (K Units) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Hydrogel-based Drug Delivery Device.
MARKET SEGMENTATION
By Company
- AstraZeneca Plc.
- Columbia Laboratories Inc.
- Mylan
- Teva Pharmaceuticals USA Inc.
- Blairex Laboratories Inc.
- ARx LLC.
- Endo International plc
- BioDelivery Sciences International Inc.
- Indivior PLC
- GSK Plc
- Pfizer Inc.
- Aquestive Therapeutics Inc.
- ZIM LABORATORIES LIMITED
- IntelGenx Corp.
- NEXGEL
- Bliss GVS Pharma Ltd.
- Teika Pharmaceutical Co. Ltd.
- Medherant Limited
- Galderma
- Johnson & Johnson
- Bausch and Lomb
- Ferring B.V
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Oral
- Buccal
- Rectal
- Vaginal
- Other
Segment by Application
- Hospital
- Clinic
- Other
CHAPTER OUTLINE
Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
Chapter 2: Provides a detailed analysis of the Hydrogel-based Drug Delivery Device manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 5: Presents Hydrogel-based Drug Delivery Device sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
Chapter 6: Presents Hydrogel-based Drug Delivery Device sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Hydrogel-based Drug Delivery Device Product Introduction
1.2 Global Hydrogel-based Drug Delivery Device Market Size Forecast
1.2.1 Global Hydrogel-based Drug Delivery Device Sales Value (2021–2032)
1.2.2 Global Hydrogel-based Drug Delivery Device Sales Volume (2021–2032)
1.2.3 Global Hydrogel-based Drug Delivery Device Sales Price (2021–2032)
1.3 Hydrogel-based Drug Delivery Device Market Trends & Drivers
1.3.1 Hydrogel-based Drug Delivery Device Industry Trends
1.3.2 Hydrogel-based Drug Delivery Device Market Drivers & Opportunities
1.3.3 Hydrogel-based Drug Delivery Device Market Challenges
1.3.4 Hydrogel-based Drug Delivery Device Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Hydrogel-based Drug Delivery Device Players Revenue Ranking (2025)
2.2 Global Hydrogel-based Drug Delivery Device Revenue by Company (2021–2026)
2.3 Global Hydrogel-based Drug Delivery Device Sales Volume Ranking of Players (2025)
2.4 Global Hydrogel-based Drug Delivery Device Sales Volume by Company (2021–2026)
2.5 Global Hydrogel-based Drug Delivery Device Average Price by Company (2021–2026)
2.6 Key Manufacturers Hydrogel-based Drug Delivery Device Manufacturing Base and Headquarters
2.7 Key Manufacturers Hydrogel-based Drug Delivery Device Product Offerings
2.8 Key Manufacturers Start of Mass Production of Hydrogel-based Drug Delivery Device
2.9 Hydrogel-based Drug Delivery Device Market Competitive Analysis
2.9.1 Hydrogel-based Drug Delivery Device Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Hydrogel-based Drug Delivery Device Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Hydrogel-based Drug Delivery Device revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Hydrogel-based Drug Delivery Device Market Classification
3.1 Introduction by Type
3.1.1 Oral
3.1.2 Buccal
3.1.3 Rectal
3.1.4 Vaginal
3.1.5 Other
3.1.6 Global Hydrogel-based Drug Delivery Device Sales Value by Type
3.1.6.1 Global Hydrogel-based Drug Delivery Device Sales Value by Type (2021 vs 2025 vs 2032)
3.1.6.2 Global Hydrogel-based Drug Delivery Device Sales Value, by Type (2021–2032)
3.1.6.3 Global Hydrogel-based Drug Delivery Device Sales Value, by Type (%), 2021–2032
3.1.7 Global Hydrogel-based Drug Delivery Device Sales Volume by Type
3.1.7.1 Global Hydrogel-based Drug Delivery Device Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.7.2 Global Hydrogel-based Drug Delivery Device Sales Volume, by Type (2021–2032)
3.1.7.3 Global Hydrogel-based Drug Delivery Device Sales Volume, by Type (%), 2021–2032
3.1.8 Global Hydrogel-based Drug Delivery Device Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Other
4.2 Global Hydrogel-based Drug Delivery Device Sales Value by Application
4.2.1 Global Hydrogel-based Drug Delivery Device Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Hydrogel-based Drug Delivery Device Sales Value, by Application (2021–2032)
4.2.3 Global Hydrogel-based Drug Delivery Device Sales Value, by Application (%), 2021–2032
4.3 Global Hydrogel-based Drug Delivery Device Sales Volume by Application
4.3.1 Global Hydrogel-based Drug Delivery Device Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Hydrogel-based Drug Delivery Device Sales Volume, by Application (2021–2032)
4.3.3 Global Hydrogel-based Drug Delivery Device Sales Volume, by Application (%), 2021–2032
4.4 Global Hydrogel-based Drug Delivery Device Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Hydrogel-based Drug Delivery Device Sales Value by Region
5.1.1 Global Hydrogel-based Drug Delivery Device Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Hydrogel-based Drug Delivery Device Sales Value by Region (2021–2026)
5.1.3 Global Hydrogel-based Drug Delivery Device Sales Value by Region (2027–2032)
5.1.4 Global Hydrogel-based Drug Delivery Device Sales Value by Region (%), 2021–2032
5.2 Global Hydrogel-based Drug Delivery Device Sales Volume by Region
5.2.1 Global Hydrogel-based Drug Delivery Device Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Hydrogel-based Drug Delivery Device Sales Volume by Region (2021–2026)
5.2.3 Global Hydrogel-based Drug Delivery Device Sales Volume by Region (2027–2032)
5.2.4 Global Hydrogel-based Drug Delivery Device Sales Volume by Region (%), 2021–2032
5.3 Global Hydrogel-based Drug Delivery Device Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Hydrogel-based Drug Delivery Device Sales Value, 2021–2032
5.4.2 North America Hydrogel-based Drug Delivery Device Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Hydrogel-based Drug Delivery Device Sales Value, 2021–2032
5.5.2 Europe Hydrogel-based Drug Delivery Device Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Hydrogel-based Drug Delivery Device Sales Value, 2021–2032
5.6.2 Asia Pacific Hydrogel-based Drug Delivery Device Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Hydrogel-based Drug Delivery Device Sales Value, 2021–2032
5.7.2 South America Hydrogel-based Drug Delivery Device Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Hydrogel-based Drug Delivery Device Sales Value, 2021–2032
5.8.2 Middle East & Africa Hydrogel-based Drug Delivery Device Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Hydrogel-based Drug Delivery Device Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Hydrogel-based Drug Delivery Device Sales Value and Sales Volume
6.2.1 Key Countries/Regions Hydrogel-based Drug Delivery Device Sales Value, 2021–2032
6.2.2 Key Countries/Regions Hydrogel-based Drug Delivery Device Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Hydrogel-based Drug Delivery Device Sales Value, 2021–2032
6.3.2 United States Hydrogel-based Drug Delivery Device Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Hydrogel-based Drug Delivery Device Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Hydrogel-based Drug Delivery Device Sales Value, 2021–2032
6.4.2 Europe Hydrogel-based Drug Delivery Device Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Hydrogel-based Drug Delivery Device Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Hydrogel-based Drug Delivery Device Sales Value, 2021–2032
6.5.2 China Hydrogel-based Drug Delivery Device Sales Value by Type (%), 2025 vs 2032
6.5.3 China Hydrogel-based Drug Delivery Device Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Hydrogel-based Drug Delivery Device Sales Value, 2021–2032
6.6.2 Japan Hydrogel-based Drug Delivery Device Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Hydrogel-based Drug Delivery Device Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Hydrogel-based Drug Delivery Device Sales Value, 2021–2032
6.7.2 South Korea Hydrogel-based Drug Delivery Device Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Hydrogel-based Drug Delivery Device Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Hydrogel-based Drug Delivery Device Sales Value, 2021–2032
6.8.2 Southeast Asia Hydrogel-based Drug Delivery Device Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Hydrogel-based Drug Delivery Device Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Hydrogel-based Drug Delivery Device Sales Value, 2021–2032
6.9.2 India Hydrogel-based Drug Delivery Device Sales Value by Type (%), 2025 vs 2032
6.9.3 India Hydrogel-based Drug Delivery Device Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 AstraZeneca Plc.
7.1.1 AstraZeneca Plc. Company Information
7.1.2 AstraZeneca Plc. Introduction and Business Overview
7.1.3 AstraZeneca Plc. Hydrogel-based Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 AstraZeneca Plc. Hydrogel-based Drug Delivery Device Product Offerings
7.1.5 AstraZeneca Plc. Recent Developments
7.2 Columbia Laboratories Inc.
7.2.1 Columbia Laboratories Inc. Company Information
7.2.2 Columbia Laboratories Inc. Introduction and Business Overview
7.2.3 Columbia Laboratories Inc. Hydrogel-based Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Columbia Laboratories Inc. Hydrogel-based Drug Delivery Device Product Offerings
7.2.5 Columbia Laboratories Inc. Recent Developments
7.3 Mylan
7.3.1 Mylan Company Information
7.3.2 Mylan Introduction and Business Overview
7.3.3 Mylan Hydrogel-based Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 Mylan Hydrogel-based Drug Delivery Device Product Offerings
7.3.5 Mylan Recent Developments
7.4 Teva Pharmaceuticals USA Inc.
7.4.1 Teva Pharmaceuticals USA Inc. Company Information
7.4.2 Teva Pharmaceuticals USA Inc. Introduction and Business Overview
7.4.3 Teva Pharmaceuticals USA Inc. Hydrogel-based Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Teva Pharmaceuticals USA Inc. Hydrogel-based Drug Delivery Device Product Offerings
7.4.5 Teva Pharmaceuticals USA Inc. Recent Developments
7.5 Blairex Laboratories Inc.
7.5.1 Blairex Laboratories Inc. Company Information
7.5.2 Blairex Laboratories Inc. Introduction and Business Overview
7.5.3 Blairex Laboratories Inc. Hydrogel-based Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 Blairex Laboratories Inc. Hydrogel-based Drug Delivery Device Product Offerings
7.5.5 Blairex Laboratories Inc. Recent Developments
7.6 ARx LLC.
7.6.1 ARx LLC. Company Information
7.6.2 ARx LLC. Introduction and Business Overview
7.6.3 ARx LLC. Hydrogel-based Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 ARx LLC. Hydrogel-based Drug Delivery Device Product Offerings
7.6.5 ARx LLC. Recent Developments
7.7 Endo International plc
7.7.1 Endo International plc Company Information
7.7.2 Endo International plc Introduction and Business Overview
7.7.3 Endo International plc Hydrogel-based Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 Endo International plc Hydrogel-based Drug Delivery Device Product Offerings
7.7.5 Endo International plc Recent Developments
7.8 BioDelivery Sciences International Inc.
7.8.1 BioDelivery Sciences International Inc. Company Information
7.8.2 BioDelivery Sciences International Inc. Introduction and Business Overview
7.8.3 BioDelivery Sciences International Inc. Hydrogel-based Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 BioDelivery Sciences International Inc. Hydrogel-based Drug Delivery Device Product Offerings
7.8.5 BioDelivery Sciences International Inc. Recent Developments
7.9 Indivior PLC
7.9.1 Indivior PLC Company Information
7.9.2 Indivior PLC Introduction and Business Overview
7.9.3 Indivior PLC Hydrogel-based Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 Indivior PLC Hydrogel-based Drug Delivery Device Product Offerings
7.9.5 Indivior PLC Recent Developments
7.10 GSK Plc
7.10.1 GSK Plc Company Information
7.10.2 GSK Plc Introduction and Business Overview
7.10.3 GSK Plc Hydrogel-based Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021–2026)
7.10.4 GSK Plc Hydrogel-based Drug Delivery Device Product Offerings
7.10.5 GSK Plc Recent Developments
7.11 Pfizer Inc.
7.11.1 Pfizer Inc. Company Information
7.11.2 Pfizer Inc. Introduction and Business Overview
7.11.3 Pfizer Inc. Hydrogel-based Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021–2026)
7.11.4 Pfizer Inc. Hydrogel-based Drug Delivery Device Product Offerings
7.11.5 Pfizer Inc. Recent Developments
7.12 Aquestive Therapeutics Inc.
7.12.1 Aquestive Therapeutics Inc. Company Information
7.12.2 Aquestive Therapeutics Inc. Introduction and Business Overview
7.12.3 Aquestive Therapeutics Inc. Hydrogel-based Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021–2026)
7.12.4 Aquestive Therapeutics Inc. Hydrogel-based Drug Delivery Device Product Offerings
7.12.5 Aquestive Therapeutics Inc. Recent Developments
7.13 ZIM LABORATORIES LIMITED
7.13.1 ZIM LABORATORIES LIMITED Company Information
7.13.2 ZIM LABORATORIES LIMITED Introduction and Business Overview
7.13.3 ZIM LABORATORIES LIMITED Hydrogel-based Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021–2026)
7.13.4 ZIM LABORATORIES LIMITED Hydrogel-based Drug Delivery Device Product Offerings
7.13.5 ZIM LABORATORIES LIMITED Recent Developments
7.14 IntelGenx Corp.
7.14.1 IntelGenx Corp. Company Information
7.14.2 IntelGenx Corp. Introduction and Business Overview
7.14.3 IntelGenx Corp. Hydrogel-based Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021–2026)
7.14.4 IntelGenx Corp. Hydrogel-based Drug Delivery Device Product Offerings
7.14.5 IntelGenx Corp. Recent Developments
7.15 NEXGEL
7.15.1 NEXGEL Company Information
7.15.2 NEXGEL Introduction and Business Overview
7.15.3 NEXGEL Hydrogel-based Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021–2026)
7.15.4 NEXGEL Hydrogel-based Drug Delivery Device Product Offerings
7.15.5 NEXGEL Recent Developments
7.16 Bliss GVS Pharma Ltd.
7.16.1 Bliss GVS Pharma Ltd. Company Information
7.16.2 Bliss GVS Pharma Ltd. Introduction and Business Overview
7.16.3 Bliss GVS Pharma Ltd. Hydrogel-based Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021–2026)
7.16.4 Bliss GVS Pharma Ltd. Hydrogel-based Drug Delivery Device Product Offerings
7.16.5 Bliss GVS Pharma Ltd. Recent Developments
7.17 Teika Pharmaceutical Co. Ltd.
7.17.1 Teika Pharmaceutical Co. Ltd. Company Information
7.17.2 Teika Pharmaceutical Co. Ltd. Introduction and Business Overview
7.17.3 Teika Pharmaceutical Co. Ltd. Hydrogel-based Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021–2026)
7.17.4 Teika Pharmaceutical Co. Ltd. Hydrogel-based Drug Delivery Device Product Offerings
7.17.5 Teika Pharmaceutical Co. Ltd. Recent Developments
7.18 Medherant Limited
7.18.1 Medherant Limited Company Information
7.18.2 Medherant Limited Introduction and Business Overview
7.18.3 Medherant Limited Hydrogel-based Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021–2026)
7.18.4 Medherant Limited Hydrogel-based Drug Delivery Device Product Offerings
7.18.5 Medherant Limited Recent Developments
7.19 Galderma
7.19.1 Galderma Company Information
7.19.2 Galderma Introduction and Business Overview
7.19.3 Galderma Hydrogel-based Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021–2026)
7.19.4 Galderma Hydrogel-based Drug Delivery Device Product Offerings
7.19.5 Galderma Recent Developments
7.20 Johnson & Johnson
7.20.1 Johnson & Johnson Company Information
7.20.2 Johnson & Johnson Introduction and Business Overview
7.20.3 Johnson & Johnson Hydrogel-based Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021–2026)
7.20.4 Johnson & Johnson Hydrogel-based Drug Delivery Device Product Offerings
7.20.5 Johnson & Johnson Recent Developments
7.21 Bausch and Lomb
7.21.1 Bausch and Lomb Company Information
7.21.2 Bausch and Lomb Introduction and Business Overview
7.21.3 Bausch and Lomb Hydrogel-based Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021–2026)
7.21.4 Bausch and Lomb Hydrogel-based Drug Delivery Device Product Offerings
7.21.5 Bausch and Lomb Recent Developments
7.22 Ferring B.V
7.22.1 Ferring B.V Company Information
7.22.2 Ferring B.V Introduction and Business Overview
7.22.3 Ferring B.V Hydrogel-based Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021–2026)
7.22.4 Ferring B.V Hydrogel-based Drug Delivery Device Product Offerings
7.22.5 Ferring B.V Recent Developments
8 Industry Chain Analysis
8.1 Hydrogel-based Drug Delivery Device Industrial Chain
8.2 Hydrogel-based Drug Delivery Device Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Hydrogel-based Drug Delivery Device Sales Model
8.5.2 Sales Channels
8.5.3 Hydrogel-based Drug Delivery Device Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Hydrogel-based Drug Delivery Device Market Trends
Table 2. Hydrogel-based Drug Delivery Device Market Drivers & Opportunities
Table 3. Hydrogel-based Drug Delivery Device Market Challenges
Table 4. Hydrogel-based Drug Delivery Device Market Restraints
Table 5. Global Hydrogel-based Drug Delivery Device Revenue by Company (US$ Million), 2021–2026
Table 6. Global Hydrogel-based Drug Delivery Device Revenue Market Share by Company (2021–2026)
Table 7. Global Hydrogel-based Drug Delivery Device Sales Volume by Company (K Units), 2021–2026
Table 8. Global Hydrogel-based Drug Delivery Device Sales Volume Market Share by Company (2021–2026)
Table 9. Global Market Hydrogel-based Drug Delivery Device Price by Company (US$/Unit), 2021–2026
Table 10. Key Manufacturers Hydrogel-based Drug Delivery Device Manufacturing Base and Headquarters
Table 11. Key Manufacturers Hydrogel-based Drug Delivery Device Product Type
Table 12. Key Manufacturers Start of Mass Production of Hydrogel-based Drug Delivery Device
Table 13. Global Hydrogel-based Drug Delivery Device Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Tier (Tier 1, Tier 2, Tier 3), based on Hydrogel-based Drug Delivery Device revenue, 2025
Table 15. Mergers & Acquisitions and Expansion Plans
Table 16. Global Hydrogel-based Drug Delivery Device Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)
Table 17. Global Hydrogel-based Drug Delivery Device Sales Value by Type (US$ Million), 2021–2026
Table 18. Global Hydrogel-based Drug Delivery Device Sales Value by Type (US$ Million), 2027–2032
Table 19. Global Hydrogel-based Drug Delivery Device Sales Market Share in Value by Type (2021–2026)
Table 20. Global Hydrogel-based Drug Delivery Device Sales Market Share in Value by Type (2027–2032)
Table 21. Global Hydrogel-based Drug Delivery Device Sales Volume by Type: 2021 vs 2025 vs 2032 (K Units)
Table 22. Global Hydrogel-based Drug Delivery Device Sales Volume by Type (K Units), 2021–2026
Table 23. Global Hydrogel-based Drug Delivery Device Sales Volume by Type (K Units), 2027–2032
Table 24. Global Hydrogel-based Drug Delivery Device Sales Market Share in Volume by Type (2021–2026)
Table 25. Global Hydrogel-based Drug Delivery Device Sales Market Share in Volume by Type (2027–2032)
Table 26. Global Hydrogel-based Drug Delivery Device Price by Type (US$/Unit), 2021–2026
Table 27. Global Hydrogel-based Drug Delivery Device Price by Type (US$/Unit), 2027–2032
Table 28. Global Hydrogel-based Drug Delivery Device Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)
Table 29. Global Hydrogel-based Drug Delivery Device Sales Value by Application (US$ Million), 2021–2026
Table 30. Global Hydrogel-based Drug Delivery Device Sales Value by Application (US$ Million), 2027–2032
Table 31. Global Hydrogel-based Drug Delivery Device Sales Market Share in Value by Application (2021–2026)
Table 32. Global Hydrogel-based Drug Delivery Device Sales Market Share in Value by Application (2027–2032)
Table 33. Global Hydrogel-based Drug Delivery Device Sales Volume by Application: 2021 vs 2025 vs 2032 (K Units)
Table 34. Global Hydrogel-based Drug Delivery Device Sales Volume by Application (K Units), 2021–2026
Table 35. Global Hydrogel-based Drug Delivery Device Sales Volume by Application (K Units), 2027–2032
Table 36. Global Hydrogel-based Drug Delivery Device Sales Market Share in Volume by Application (2021–2026)
Table 37. Global Hydrogel-based Drug Delivery Device Sales Market Share in Volume by Application (2027–2032)
Table 38. Global Hydrogel-based Drug Delivery Device Price by Application (US$/Unit), 2021–2026
Table 39. Global Hydrogel-based Drug Delivery Device Price by Application (US$/Unit), 2027–2032
Table 40. Global Hydrogel-based Drug Delivery Device Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032
Table 41. Global Hydrogel-based Drug Delivery Device Sales Value by Region (US$ Million), 2021–2026
Table 42. Global Hydrogel-based Drug Delivery Device Sales Value by Region (US$ Million), 2027–2032
Table 43. Global Hydrogel-based Drug Delivery Device Sales Value by Region (%), 2021–2026
Table 44. Global Hydrogel-based Drug Delivery Device Sales Value by Region (%), 2027–2032
Table 45. Global Hydrogel-based Drug Delivery Device Sales Volume by Region (K Units): 2021 vs 2025 vs 2032
Table 46. Global Hydrogel-based Drug Delivery Device Sales Volume by Region (K Units), 2021–2026
Table 47. Global Hydrogel-based Drug Delivery Device Sales Volume by Region (K Units), 2027–2032
Table 48. Global Hydrogel-based Drug Delivery Device Sales Volume by Region (%), 2021–2026
Table 49. Global Hydrogel-based Drug Delivery Device Sales Volume by Region (%), 2027–2032
Table 50. Global Hydrogel-based Drug Delivery Device Average Price by Region (US$/Unit), 2021–2026
Table 51. Global Hydrogel-based Drug Delivery Device Average Price by Region (US$/Unit), 2027–2032
Table 52. Key Countries/Regions Hydrogel-based Drug Delivery Device Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032
Table 53. Key Countries/Regions Hydrogel-based Drug Delivery Device Sales Value, (US$ Million), 2021–2026
Table 54. Key Countries/Regions Hydrogel-based Drug Delivery Device Sales Value, (US$ Million), 2027–2032
Table 55. Key Countries/Regions Hydrogel-based Drug Delivery Device Sales Volume, (K Units), 2021–2026
Table 56. Key Countries/Regions Hydrogel-based Drug Delivery Device Sales Volume, (K Units), 2027–2032
Table 57. AstraZeneca Plc. Company Information
Table 58. AstraZeneca Plc. Introduction and Business Overview
Table 59. AstraZeneca Plc. Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 60. AstraZeneca Plc. Hydrogel-based Drug Delivery Device Product Offerings
Table 61. AstraZeneca Plc. Recent Developments
Table 62. Columbia Laboratories Inc. Company Information
Table 63. Columbia Laboratories Inc. Introduction and Business Overview
Table 64. Columbia Laboratories Inc. Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 65. Columbia Laboratories Inc. Hydrogel-based Drug Delivery Device Product Offerings
Table 66. Columbia Laboratories Inc. Recent Developments
Table 67. Mylan Company Information
Table 68. Mylan Introduction and Business Overview
Table 69. Mylan Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 70. Mylan Hydrogel-based Drug Delivery Device Product Offerings
Table 71. Mylan Recent Developments
Table 72. Teva Pharmaceuticals USA Inc. Company Information
Table 73. Teva Pharmaceuticals USA Inc. Introduction and Business Overview
Table 74. Teva Pharmaceuticals USA Inc. Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 75. Teva Pharmaceuticals USA Inc. Hydrogel-based Drug Delivery Device Product Offerings
Table 76. Teva Pharmaceuticals USA Inc. Recent Developments
Table 77. Blairex Laboratories Inc. Company Information
Table 78. Blairex Laboratories Inc. Introduction and Business Overview
Table 79. Blairex Laboratories Inc. Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 80. Blairex Laboratories Inc. Hydrogel-based Drug Delivery Device Product Offerings
Table 81. Blairex Laboratories Inc. Recent Developments
Table 82. ARx LLC. Company Information
Table 83. ARx LLC. Introduction and Business Overview
Table 84. ARx LLC. Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 85. ARx LLC. Hydrogel-based Drug Delivery Device Product Offerings
Table 86. ARx LLC. Recent Developments
Table 87. Endo International plc Company Information
Table 88. Endo International plc Introduction and Business Overview
Table 89. Endo International plc Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 90. Endo International plc Hydrogel-based Drug Delivery Device Product Offerings
Table 91. Endo International plc Recent Developments
Table 92. BioDelivery Sciences International Inc. Company Information
Table 93. BioDelivery Sciences International Inc. Introduction and Business Overview
Table 94. BioDelivery Sciences International Inc. Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 95. BioDelivery Sciences International Inc. Hydrogel-based Drug Delivery Device Product Offerings
Table 96. BioDelivery Sciences International Inc. Recent Developments
Table 97. Indivior PLC Company Information
Table 98. Indivior PLC Introduction and Business Overview
Table 99. Indivior PLC Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 100. Indivior PLC Hydrogel-based Drug Delivery Device Product Offerings
Table 101. Indivior PLC Recent Developments
Table 102. GSK Plc Company Information
Table 103. GSK Plc Introduction and Business Overview
Table 104. GSK Plc Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 105. GSK Plc Hydrogel-based Drug Delivery Device Product Offerings
Table 106. GSK Plc Recent Developments
Table 107. Pfizer Inc. Company Information
Table 108. Pfizer Inc. Introduction and Business Overview
Table 109. Pfizer Inc. Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 110. Pfizer Inc. Hydrogel-based Drug Delivery Device Product Offerings
Table 111. Pfizer Inc. Recent Developments
Table 112. Aquestive Therapeutics Inc. Company Information
Table 113. Aquestive Therapeutics Inc. Introduction and Business Overview
Table 114. Aquestive Therapeutics Inc. Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 115. Aquestive Therapeutics Inc. Hydrogel-based Drug Delivery Device Product Offerings
Table 116. Aquestive Therapeutics Inc. Recent Developments
Table 117. ZIM LABORATORIES LIMITED Company Information
Table 118. ZIM LABORATORIES LIMITED Introduction and Business Overview
Table 119. ZIM LABORATORIES LIMITED Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 120. ZIM LABORATORIES LIMITED Hydrogel-based Drug Delivery Device Product Offerings
Table 121. ZIM LABORATORIES LIMITED Recent Developments
Table 122. IntelGenx Corp. Company Information
Table 123. IntelGenx Corp. Introduction and Business Overview
Table 124. IntelGenx Corp. Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 125. IntelGenx Corp. Hydrogel-based Drug Delivery Device Product Offerings
Table 126. IntelGenx Corp. Recent Developments
Table 127. NEXGEL Company Information
Table 128. NEXGEL Introduction and Business Overview
Table 129. NEXGEL Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 130. NEXGEL Hydrogel-based Drug Delivery Device Product Offerings
Table 131. NEXGEL Recent Developments
Table 132. Bliss GVS Pharma Ltd. Company Information
Table 133. Bliss GVS Pharma Ltd. Introduction and Business Overview
Table 134. Bliss GVS Pharma Ltd. Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 135. Bliss GVS Pharma Ltd. Hydrogel-based Drug Delivery Device Product Offerings
Table 136. Bliss GVS Pharma Ltd. Recent Developments
Table 137. Teika Pharmaceutical Co. Ltd. Company Information
Table 138. Teika Pharmaceutical Co. Ltd. Introduction and Business Overview
Table 139. Teika Pharmaceutical Co. Ltd. Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 140. Teika Pharmaceutical Co. Ltd. Hydrogel-based Drug Delivery Device Product Offerings
Table 141. Teika Pharmaceutical Co. Ltd. Recent Developments
Table 142. Medherant Limited Company Information
Table 143. Medherant Limited Introduction and Business Overview
Table 144. Medherant Limited Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 145. Medherant Limited Hydrogel-based Drug Delivery Device Product Offerings
Table 146. Medherant Limited Recent Developments
Table 147. Galderma Company Information
Table 148. Galderma Introduction and Business Overview
Table 149. Galderma Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 150. Galderma Hydrogel-based Drug Delivery Device Product Offerings
Table 151. Galderma Recent Developments
Table 152. Johnson & Johnson Company Information
Table 153. Johnson & Johnson Introduction and Business Overview
Table 154. Johnson & Johnson Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 155. Johnson & Johnson Hydrogel-based Drug Delivery Device Product Offerings
Table 156. Johnson & Johnson Recent Developments
Table 157. Bausch and Lomb Company Information
Table 158. Bausch and Lomb Introduction and Business Overview
Table 159. Bausch and Lomb Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 160. Bausch and Lomb Hydrogel-based Drug Delivery Device Product Offerings
Table 161. Bausch and Lomb Recent Developments
Table 162. Ferring B.V Company Information
Table 163. Ferring B.V Introduction and Business Overview
Table 164. Ferring B.V Hydrogel-based Drug Delivery Device Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021–2026)
Table 165. Ferring B.V Hydrogel-based Drug Delivery Device Product Offerings
Table 166. Ferring B.V Recent Developments
Table 167. Key Raw Materials Lists
Table 168. Key Suppliers of Raw Materials Lists
Table 169. Hydrogel-based Drug Delivery Device Downstream Customers
Table 170. Hydrogel-based Drug Delivery Device Distributors List
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources
List of Figures
Figure 1. Hydrogel-based Drug Delivery Device Product Picture
Figure 2. Global Hydrogel-based Drug Delivery Device Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Global Hydrogel-based Drug Delivery Device Sales Value (US$ Million), 2021–2032
Figure 4. Global Hydrogel-based Drug Delivery Device Sales Volume (K Units), 2021–2032
Figure 5. Global Hydrogel-based Drug Delivery Device Sales Price (US$/Unit), 2021–2032
Figure 6. Hydrogel-based Drug Delivery Device Report Years Considered
Figure 7. Global Hydrogel-based Drug Delivery Device Players Revenue Ranking (US$ Million), 2025
Figure 8. Global Hydrogel-based Drug Delivery Device Sales Volume Ranking of Players (K Units), 2025
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Hydrogel-based Drug Delivery Device Revenue in 2025
Figure 10. Hydrogel-based Drug Delivery Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 11. Oral Picture
Figure 12. Buccal Picture
Figure 13. Rectal Picture
Figure 14. Vaginal Picture
Figure 15. Other Picture
Figure 16. Global Hydrogel-based Drug Delivery Device Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
Figure 17. Global Hydrogel-based Drug Delivery Device Sales Value Market Share by Type, 2025 & 2032
Figure 18. Global Hydrogel-based Drug Delivery Device Sales Volume by Type (K Units), 2021 vs 2025 vs 2032
Figure 19. Global Hydrogel-based Drug Delivery Device Sales Volume Market Share by Type, 2025 & 2032
Figure 20. Global Hydrogel-based Drug Delivery Device Price by Type (US$/Unit), 2021–2032
Figure 21. Product Picture of Hospital
Figure 22. Product Picture of Clinic
Figure 23. Product Picture of Other
Figure 24. Global Hydrogel-based Drug Delivery Device Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
Figure 25. Global Hydrogel-based Drug Delivery Device Sales Value Market Share by Application, 2025 & 2032
Figure 26. Global Hydrogel-based Drug Delivery Device Sales Volume by Application (K Units), 2021 vs 2025 vs 2032
Figure 27. Global Hydrogel-based Drug Delivery Device Sales Volume Market Share by Application, 2025 & 2032
Figure 28. Global Hydrogel-based Drug Delivery Device Price by Application (US$/Unit), 2021–2032
Figure 29. North America Hydrogel-based Drug Delivery Device Sales Value (US$ Million), 2021–2032
Figure 30. North America Hydrogel-based Drug Delivery Device Sales Value by Country (%), 2025 vs 2032
Figure 31. Europe Hydrogel-based Drug Delivery Device Sales Value (US$ Million), 2021–2032
Figure 32. Europe Hydrogel-based Drug Delivery Device Sales Value by Country (%), 2025 vs 2032
Figure 33. Asia Pacific Hydrogel-based Drug Delivery Device Sales Value (US$ Million), 2021–2032
Figure 34. Asia Pacific Hydrogel-based Drug Delivery Device Sales Value by Region (%), 2025 vs 2032
Figure 35. South America Hydrogel-based Drug Delivery Device Sales Value (US$ Million), 2021–2032
Figure 36. South America Hydrogel-based Drug Delivery Device Sales Value by Country (%), 2025 vs 2032
Figure 37. Middle East & Africa Hydrogel-based Drug Delivery Device Sales Value (US$ Million), 2021–2032
Figure 38. Middle East & Africa Hydrogel-based Drug Delivery Device Sales Value by Country (%), 2025 vs 2032
Figure 39. Key Countries/Regions Hydrogel-based Drug Delivery Device Sales Value (%), 2021–2032
Figure 40. Key Countries/Regions Hydrogel-based Drug Delivery Device Sales Volume (%), 2021–2032
Figure 41. United States Hydrogel-based Drug Delivery Device Sales Value (US$ Million), 2021–2032
Figure 42. United States Hydrogel-based Drug Delivery Device Sales Value by Type (%), 2025 vs 2032
Figure 43. United States Hydrogel-based Drug Delivery Device Sales Value by Application (%), 2025 vs 2032
Figure 44. Europe Hydrogel-based Drug Delivery Device Sales Value (US$ Million), 2021–2032
Figure 45. Europe Hydrogel-based Drug Delivery Device Sales Value by Type (%), 2025 vs 2032
Figure 46. Europe Hydrogel-based Drug Delivery Device Sales Value by Application (%), 2025 vs 2032
Figure 47. China Hydrogel-based Drug Delivery Device Sales Value (US$ Million), 2021–2032
Figure 48. China Hydrogel-based Drug Delivery Device Sales Value by Type (%), 2025 vs 2032
Figure 49. China Hydrogel-based Drug Delivery Device Sales Value by Application (%), 2025 vs 2032
Figure 50. Japan Hydrogel-based Drug Delivery Device Sales Value (US$ Million), 2021–2032
Figure 51. Japan Hydrogel-based Drug Delivery Device Sales Value by Type (%), 2025 vs 2032
Figure 52. Japan Hydrogel-based Drug Delivery Device Sales Value by Application (%), 2025 vs 2032
Figure 53. South Korea Hydrogel-based Drug Delivery Device Sales Value (US$ Million), 2021–2032
Figure 54. South Korea Hydrogel-based Drug Delivery Device Sales Value by Type (%), 2025 vs 2032
Figure 55. South Korea Hydrogel-based Drug Delivery Device Sales Value by Application (%), 2025 vs 2032
Figure 56. Southeast Asia Hydrogel-based Drug Delivery Device Sales Value (US$ Million), 2021–2032
Figure 57. Southeast Asia Hydrogel-based Drug Delivery Device Sales Value by Type (%), 2025 vs 2032
Figure 58. Southeast Asia Hydrogel-based Drug Delivery Device Sales Value by Application (%), 2025 vs 2032
Figure 59. India Hydrogel-based Drug Delivery Device Sales Value (US$ Million), 2021–2032
Figure 60. India Hydrogel-based Drug Delivery Device Sales Value by Type (%), 2025 vs 2032
Figure 61. India Hydrogel-based Drug Delivery Device Sales Value by Application (%), 2025 vs 2032
Figure 62. Hydrogel-based Drug Delivery Device Industrial Chain
Figure 63. Hydrogel-based Drug Delivery Device Manufacturing Cost Structure
Figure 64. Channels of Distribution (Direct Sales, and Distribution)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
Which companies rank high in the global Hydrogel-based Drug Delivery Device market?
The top companies in the global Hydrogel-based Drug Delivery Device market are AstraZeneca Plc.、Columbia Laboratories Inc.、Mylan.
Related Reports
Global Hydrogel-based Drug Delivery Device Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Hydrogel-based Drug Delivery Device market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 198
USD 4900.00
(Single User License)
Global Hydrogel-based Drug Delivery Device Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hydrogel-based Drug Delivery Device market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 119
USD 4250.00
(Single User License)
Global Hydrogel-based Drug Delivery Device Market Research Report 2026
The global Hydrogel-based Drug Delivery Device market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-14
Pages: 140
USD 2900.00
(Single User License)
Global Hydrogel-based Drug Delivery Device Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Hydrogel-based Drug Delivery Device market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 197
USD 4900.00
(Single User License)
Global Hydrogel-based Drug Delivery Device Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hydrogel-based Drug Delivery Device market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 117
USD 4250.00
(Single User License)
Hydrogel-based Drug Delivery Device - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hydrogel-based Drug Delivery Device was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 168
USD 3950.00
(Single User License)
Global Hydrogel-based Drug Delivery Device Market Research Report 2025
The global market for Hydrogel-based Drug Delivery Device was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 112
USD 2900.00
(Single User License)
Global and United States Hydrogel-based Drug Delivery Device Market Report & Forecast 2024-2030
A hydrogel-based drug delivery device refers to a biomedical technology that uses hydrogels as matrices or carriers for controlled and targeted release of therapeutic agents. Hydrogels are three-dimensional networks of cross-linked hydrophilic polymers capable of absorbing and retaining large amounts of water. These devices are designed to encapsulate drugs or biomolecules, providing a stable environment for sustained or localized release in response to physiological stimuli such as pH, temperature, or enzymatic activity. Hydrogel-based drug delivery systems offer advantages like enhanced bioavailability, reduced systemic side effects, and prolonged therapeutic efficacy. They are utilized in various medical applications including wound healing, tissue engineering, cancer therapy, and treatment of chronic diseases, demonstrating versatility and potential for personalized medicine approaches.
Published Date: 2024-07-07
Pages: 179
USD 4350.00
(Single User License)
Global Hydrogel-based Drug Delivery Device Market Insights, Forecast to 2030
A hydrogel-based drug delivery device refers to a biomedical technology that uses hydrogels as matrices or carriers for controlled and targeted release of therapeutic agents. Hydrogels are three-dimensional networks of cross-linked hydrophilic polymers capable of absorbing and retaining large amounts of water. These devices are designed to encapsulate drugs or biomolecules, providing a stable environment for sustained or localized release in response to physiological stimuli such as pH, temperature, or enzymatic activity. Hydrogel-based drug delivery systems offer advantages like enhanced bioavailability, reduced systemic side effects, and prolonged therapeutic efficacy. They are utilized in various medical applications including wound healing, tissue engineering, cancer therapy, and treatment of chronic diseases, demonstrating versatility and potential for personalized medicine approaches.
Published Date: 2024-07-07
Pages: 192
USD 4900.00
(Single User License)
Global Hydrogel-based Drug Delivery Device Market Research Report 2024
A hydrogel-based drug delivery device refers to a biomedical technology that uses hydrogels as matrices or carriers for controlled and targeted release of therapeutic agents. Hydrogels are three-dimensional networks of cross-linked hydrophilic polymers capable of absorbing and retaining large amounts of water. These devices are designed to encapsulate drugs or biomolecules, providing a stable environment for sustained or localized release in response to physiological stimuli such as pH, temperature, or enzymatic activity. Hydrogel-based drug delivery systems offer advantages like enhanced bioavailability, reduced systemic side effects, and prolonged therapeutic efficacy. They are utilized in various medical applications including wound healing, tissue engineering, cancer therapy, and treatment of chronic diseases, demonstrating versatility and potential for personalized medicine approaches.
Published Date: 2024-07-07
Pages: 109
USD 2900.00
(Single User License)
Global Hydrogel-based Drug Delivery Device Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Hydrogel-based Drug Delivery Device market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 198
USD 4900.00 (Single User License)Global Hydrogel-based Drug Delivery Device Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hydrogel-based Drug Delivery Device market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 119
USD 4250.00 (Single User License)Global Hydrogel-based Drug Delivery Device Market Research Report 2026
The global Hydrogel-based Drug Delivery Device market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-14
Pages: 140
USD 2900.00 (Single User License)Global Hydrogel-based Drug Delivery Device Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Hydrogel-based Drug Delivery Device market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 197
USD 4900.00 (Single User License)Global Hydrogel-based Drug Delivery Device Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hydrogel-based Drug Delivery Device market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 117
USD 4250.00 (Single User License)Hydrogel-based Drug Delivery Device - Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hydrogel-based Drug Delivery Device was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 168
USD 3950.00 (Single User License)Global Hydrogel-based Drug Delivery Device Market Research Report 2025
The global market for Hydrogel-based Drug Delivery Device was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 112
USD 2900.00 (Single User License)Global and United States Hydrogel-based Drug Delivery Device Market Report & Forecast 2024-2030
A hydrogel-based drug delivery device refers to a biomedical technology that uses hydrogels as matrices or carriers for controlled and targeted release of therapeutic agents. Hydrogels are three-dimensional networks of cross-linked hydrophilic polymers capable of absorbing and retaining large amounts of water. These devices are designed to encapsulate drugs or biomolecules, providing a stable environment for sustained or localized release in response to physiological stimuli such as pH, temperature, or enzymatic activity. Hydrogel-based drug delivery systems offer advantages like enhanced bioavailability, reduced systemic side effects, and prolonged therapeutic efficacy. They are utilized in various medical applications including wound healing, tissue engineering, cancer therapy, and treatment of chronic diseases, demonstrating versatility and potential for personalized medicine approaches.
Published: 2024-07-07
Pages: 179
USD 4350.00 (Single User License)Global Hydrogel-based Drug Delivery Device Market Insights, Forecast to 2030
A hydrogel-based drug delivery device refers to a biomedical technology that uses hydrogels as matrices or carriers for controlled and targeted release of therapeutic agents. Hydrogels are three-dimensional networks of cross-linked hydrophilic polymers capable of absorbing and retaining large amounts of water. These devices are designed to encapsulate drugs or biomolecules, providing a stable environment for sustained or localized release in response to physiological stimuli such as pH, temperature, or enzymatic activity. Hydrogel-based drug delivery systems offer advantages like enhanced bioavailability, reduced systemic side effects, and prolonged therapeutic efficacy. They are utilized in various medical applications including wound healing, tissue engineering, cancer therapy, and treatment of chronic diseases, demonstrating versatility and potential for personalized medicine approaches.
Published: 2024-07-07
Pages: 192
USD 4900.00 (Single User License)Global Hydrogel-based Drug Delivery Device Market Research Report 2024
A hydrogel-based drug delivery device refers to a biomedical technology that uses hydrogels as matrices or carriers for controlled and targeted release of therapeutic agents. Hydrogels are three-dimensional networks of cross-linked hydrophilic polymers capable of absorbing and retaining large amounts of water. These devices are designed to encapsulate drugs or biomolecules, providing a stable environment for sustained or localized release in response to physiological stimuli such as pH, temperature, or enzymatic activity. Hydrogel-based drug delivery systems offer advantages like enhanced bioavailability, reduced systemic side effects, and prolonged therapeutic efficacy. They are utilized in various medical applications including wound healing, tissue engineering, cancer therapy, and treatment of chronic diseases, demonstrating versatility and potential for personalized medicine approaches.
Published: 2024-07-07
Pages: 109
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 3950.00
USD 5925.00
USD 7900.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now